Literature DB >> 7537428

Coexpression of stem cell factor and its receptor c-Kit in human malignant glioma cell lines.

M Stanulla1, K Welte, M R Hadam, T Pietsch.   

Abstract

Stem cell factor (SCF), a hematopoietic growth factor, is the ligand of the tyrosine kinase receptor encoded by the c-kit proto-oncogene. Beside the important role of this receptor-ligand complex in hematopoiesis, gametogenesis and melanogenesis, SCF and its receptor have been shown to be expressed in the brain. We have studied the expression of SCF and c-kit in 20 human malignant glioma cell lines at the mRNA as well as at the protein level. In addition, recombinant human (rh) SCF was tested in [3H]thymidine uptake assays for a mitogenic effect on these cells. SCF and c-Kit proteins were detected in the cytoplasm of glioma cells by alkaline phosphatase-monoclonal anti-alkaline phosphatase immunostaining and Western blot analysis. However, neither SCF nor c-Kit were seen on the cell surface by flow cytometry. Furthermore, none of the proliferation assays showed a mitogenic effect for exogenously added rhSCF. Blocking studies using an anti-SCF antibody failed to demonstrate modulating effects on the growth of selected cell lines. These results suggest that SCF and c-Kit may mediate non-proliferative signals or may employ intracellular mechanisms for autocrine growth regulation of glioma cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537428     DOI: 10.1007/bf00296360

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  32 in total

1.  Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant.

Authors:  J G Flanagan; D C Chan; P Leder
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

2.  COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth.

Authors:  C E Dunbar; T M Browder; J S Abrams; A W Nienhuis
Journal:  Science       Date:  1989-09-29       Impact factor: 47.728

Review 3.  Hereditary anemias of the mouse: a review for geneticists.

Authors:  E S Russell
Journal:  Adv Genet       Date:  1979       Impact factor: 1.944

4.  Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium.

Authors:  K M Zsebo; J Wypych; I K McNiece; H S Lu; K A Smith; S B Karkare; R K Sachdev; V N Yuschenkoff; N C Birkett; L R Williams
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

5.  Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms.

Authors:  D M Anderson; S D Lyman; A Baird; J M Wignall; J Eisenman; C Rauch; C J March; H S Boswell; S D Gimpel; D Cosman
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

6.  Expression of c-kit receptor in normal and transformed human nonlymphoid tissues.

Authors:  P G Natali; M R Nicotra; I Sures; E Santoro; A Bigotti; A Ullrich
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

7.  Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene.

Authors:  W E Berdel; S de Vos; J Maurer; D Oberberg; Z von Marschall; J K Schroeder; J Li; W D Ludwig; E D Kreuser; E Thiel
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

8.  Loss of c-kit expression in cultured melanoma cells.

Authors:  N Lassam; S Bickford
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

9.  Antigenic phenotypes of cultured malignant astrocytomas: identification of lineage-consistent, lineage-independent and putative tumor-restricted antigenic expression.

Authors:  M T Jennings; V D Jennings; L L Asadourian; S A Ebrahim; C E Klein; L J Old
Journal:  J Neurol Sci       Date:  1989-01       Impact factor: 3.181

10.  Autocrine stimulation by the v-sis gene product requires a ligand-receptor interaction at the cell surface.

Authors:  M Hannink; D J Donoghue
Journal:  J Cell Biol       Date:  1988-07       Impact factor: 10.539

View more
  12 in total

1.  Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.

Authors:  C Haberler; E Gelpi; C Marosi; K Rössler; P Birner; H Budka; J A Hainfellner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

2.  Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit protooncogene.

Authors:  J He; C M deCastro; G R Vandenbark; J Busciglio; D Gabuzda
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 3.  Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas.

Authors:  A Besson; V W Yong
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

4.  CD117 expression in glial tumors.

Authors:  Neslihan Cetin; Gerald Dienel; Murat Gokden
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

Review 5.  The road less travelled: c-kit and stem cell factor.

Authors:  W Hamel; M Westphal
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

Review 6.  Molecular neuropathology of astrocytic brain tumors.

Authors:  T Pietsch; O D Wiestler
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

7.  Imatinib and docetaxel in combination can effectively inhibit glioma invasion in an in vitro 3D invasion assay.

Authors:  Paula Kinsella; Martin Clynes; Verena Amberger-Murphy
Journal:  J Neurooncol       Date:  2010-05-30       Impact factor: 4.130

8.  Expression of proto-oncogene KIT is up-regulated in subset of human meningiomas.

Authors:  Masum Saini; Ajaya Nand Jha; Andleeb Abrari; Sher Ali
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

9.  Selective migration of neuralized embryonic stem cells to stem cell factor and media conditioned by glioma cell lines.

Authors:  Peter Serfozo; Maggie S Schlarman; Chris Pierret; Bernard L Maria; Mark D Kirk
Journal:  Cancer Cell Int       Date:  2006-01-25       Impact factor: 5.722

Review 10.  Stemming cancer: functional genomics of cancer stem cells in solid tumors.

Authors:  C R A Regenbrecht; H Lehrach; J Adjaye
Journal:  Stem Cell Rev       Date:  2008-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.